One notable advantage of Renaissance Capital is its below-average fees. On average, the firm's open-end and exchange-traded fund fees fall in the lowest quintile of category peers. Renaissance Capital fails to showcase longevity across its product shelf, as evidenced by its three-year risk-adjusted success ratio. Over this time period, only 0% of its roster has been able to both survive and beat its respective category median on a risk-adjusted basis. A low success ratio indicates poor performance and raises questions about a firm’s discipline around investment strategy and product development. With an average three-year Morningstar Rating of 1.0 stars, the risk-adjusted performance of Renaissance Capital's open-end and exchange-traded funds falls short of competitors.
Best Stocks and Funds to Invest in Nuclear Energy
Nuclear power is undergoing a renaissance but won’t be a big theme for most US utilities.